Skip to content

LifeStance Health Group LFST Non Cash Operating Lease Costs

Non Cash Operating Lease Costs at other companies

Clearwater Analytics logo
Clearwater AnalyticsCWAN
$4.12M+73.6%
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$34K+17.2%
PBH
Prestige Consumer HealthcarePBH
$2.04M+5.8%
Restoration Hardware logo
Restoration HardwareRH
$27.49M+9.1%
SentinelOne logo
SentinelOneS
$1.06M-3.5%
Shake Shack logo
Shake ShackSHAK
$24.69M+19.4%

Other financials

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04

Balance sheet

See full
Cash & equivalents$194.8M+45.0%
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation

See full
Market cap$3.6B-4.8%

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept lfst:NonCashOperatingLeaseCosts.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's non cash operating lease costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeStance Health Group's non cash operating lease costs?
LifeStance Health Group (LFST) reported non cash operating lease costs of $10.72M in Q1 2026.
How has LifeStance Health Group's non cash operating lease costs changed year-over-year?
LifeStance Health Group's non cash operating lease costs increased by 4.8% year-over-year, from $10.23M to $10.72M.
What does non cash operating lease costs mean?
This metric represents the non-cash expense recognized for operating leases under accounting standards like ASC 842. It reflects the systematic allocation of the right-of-use asset cost over the lease term, which is added back to net income in the cash flow statement. Monitoring this helps investors understand the underlying operational cost structure independent of actual cash lease payments.